Skip to content

Fanconi Anemia Complementation Group C C3468041

Published: July 22, 2026Updated: August 20, 2026

A genetic condition affecting the body's ability to repair DNA damage. Leads to bone marrow failure, physical abnormalities, and higher cancer risk. Management involves regular monitoring and potential transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D61.03
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Pancytopenia

(hematologic)

Easy bruising

(hematologic)

Neutropenia

(hematologic)

Hearing loss

(ear)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hematopoietic Stem Cell Transplantation

Curative allogeneic transplantation for FANCC patients with bone marrow failure uses fludarabine-based reduced intensity conditioning to minimize toxicity while achieving engraftment.

surgical
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Androgen Therapy

Synthetic androgen therapy improves blood counts in many FANCC patients, serving as first-line therapy while evaluating transplant options or as supportive care for non-transplant candidates.

medication

Additional treatment options

Annual Cancer Screening

Comprehensive cancer surveillance including dermatologic, gynecologic, and ENT examinations detects early malignancies which are more common in FA patients.

monitoring

Eltrombopag Therapy

Thrombopoietin receptor agonist may be used off-label to support platelet counts in FANCC patients with thrombocytopenia, though data in FA is limited.

procedure

Family Genetic Counseling

Genetic counseling helps families understand inheritance patterns, recurrence risks, and available reproductive options including prenatal diagnosis and preimplantation genetic testing.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Fanconi Anemia Complementation Group C C3468041?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Fanconi Anemia Complementation Group C C3468041. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy